Pharmalink

This page shows the latest Pharmalink news and features for those working in and with pharma, biotech and healthcare.

Pharmalink appoints new chairman Anders Wiklund

Anders Wiklund has joined Swedish specialty pharma company Pharmalink AB as chairman of the board. ... Julander, who founded the company in 1991, will remain on Pharmalink's board as a non-executive director, as will Lennart Hansson.

Latest news

News in brief, July 04, 2007

Eli Lilly divests Distaclor antibiotic. The Indian subsidiary of global pharmaceutical major Eli Lilly has divested its antibiotic Distaclor (cefaclor) to Pharmalink, a subsidiary of Quintiles International, for an undisclosed sum,

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

ReNeuron appoints new CEO

Hellebø, who has also previously held directorship positions at Pharmalink and Palma Biotech, said ReNeuron impressed him with their technology, team and strong investment backing.
Pharmalink appoints Dr Heather Cook and Marek Poszepczynski

Strengthens senior management team. Pharmalink has bolstered its senior management team with the appointment of Dr Heather Cook and Marek Poszepcynski (pictured). ... Pharmalink's other senior management appointment is Marek Poszepcynski who takes up

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

Working together against COVID-19: Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19: Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?: Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....